National Bank of Canada
BNGO icon

National Bank of Canada’s Bionano Genomics BNGO Stock Holding History

National Bank of Canada’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– -$9K – 2857
2021
Q4 		– Hold
0
– – – 2380

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

National Bank of Canada's BNGO Position: Q2 2026 in Review

National Bank of Canada held its Bionano Genomics (BNGO) position steady in Q2 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #3109.

National Bank of Canada first reported a position in BNGO in Q4 2021 and has held it in 10 quarters since. The position peaked at $10K in Q4 2021. 13 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • National Bank of Canada held 2 shares of Bionano Genomics worth $2 as of Q2 2026.
  • National Bank of Canada left its Bionano Genomics share count unchanged in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #3109 holding.
  • National Bank of Canada first reported a position in Bionano Genomics in Q4 2021 and has held it in 10 quarters since.
  • National Bank of Canada's Bionano Genomics position peaked at $10K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.